B
Biovaxys Technology Corp
OTC:BVAXF
Biovaxys Technology Corp
OTC:BVAXF
Price:
0.107
USD
-1.2%
Market Closed
Market Cap:
$23.6m
Balance Sheet
Balance Sheet Decomposition
Biovaxys Technology Corp
Biovaxys Technology Corp
Balance Sheet Decomposition is not available for
Biovaxys Technology Corp
Biovaxys Technology Corp
Balance Sheet
Biovaxys Technology Corp
Biovaxys Technology Corp
Currency: CAD
| Oct-2018 | Oct-2019 | Oct-2020 | Oct-2021 | Oct-2022 | Oct-2023 | Oct-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
|
| Total Current Assets |
0
|
0
|
3
|
1
|
1
|
0
|
1
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
7
|
7
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+182%
|
10
+3 315%
|
9
-19%
|
1
-90%
|
0
-87%
|
1
+1 046%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
0
|
1
|
0
|
1
|
3
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Total Current Liabilities |
0
|
0
|
1
|
0
|
2
|
3
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-37%
|
1
+675%
|
0
-64%
|
2
+401%
|
3
+113%
|
3
-8%
|
|
| Equity | ||||||||
| Common Stock |
0
|
1
|
11
|
15
|
17
|
22
|
27
|
|
| Retained Earnings |
0
|
0
|
1
|
7
|
18
|
25
|
29
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
0
N/A
|
10
+4 928%
|
8
-14%
|
1
N/A
|
3
-336%
|
2
+43%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+182%
|
10
+3 315%
|
9
-19%
|
1
-90%
|
0
-87%
|
1
+1 046%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
2
|
2
|
7
|
9
|
11
|
15
|
26
|
|
Switch to:
Switch to:
See Also
Discover More
